Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination | Nature Communications
https://www.nature.com/articles/s41467-021-22929-zCancer vaccine with minimal side effects nearing Phase 3 clinical trials - ABC News
https://abcnews.go.com/Health/melanoma-cancer-vaccine-minimal-side-effects-nearing-phase/story?id=106521186Landmark brain cancer vaccine passes first phase of human trials
https://newatlas.com/medical/brain-cancer-vaccine-idh1-glioma-human-trials/PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy | Nature Communications
https://www.nature.com/articles/s41467-021-23244-3Personalized melanoma vaccines show lasting effects – Harvard Gazette
https://news.harvard.edu/gazette/story/2021/04/personalized-melanoma-vaccines-show-lasting-effects/Scientist behind COVID-19 mRNA vaccine says her team's next target is cancer | CBC News
https://www.cbc.ca/news/health/covid-19-scientist-mrna-cancer-1.5956150Thousands to trial personalised cancer vaccines
https://www.bbc.com/news/articles/cl77qvd2krgoVaccines to treat cancer possible by 2030, say BioNTech founders | Cancer | The Guardian
https://www.theguardian.com/society/2022/oct/16/vaccines-to-treat-cancer-possible-by-2030-say-biontech-founders